Cargando…

Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers

OBJECTIVES: Leber’s hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by a variable and reduced penetrance. Individuals carrying a primary LHON-causing mitochondrial DNA (mtDNA) mutation may either remain asymptomatic lifelong, as unaffected carriers, or develop sud...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianco, Angelica, Valletti, Alessio, Longo, Giovanna, Bisceglia, Luigi, Montoya, Julio, Emperador, Sonia, Guerriero, Silvana, Petruzzella, Vittoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302380/
https://www.ncbi.nlm.nih.gov/pubmed/30572950
http://dx.doi.org/10.1186/s13104-018-4025-y
_version_ 1783381965364264960
author Bianco, Angelica
Valletti, Alessio
Longo, Giovanna
Bisceglia, Luigi
Montoya, Julio
Emperador, Sonia
Guerriero, Silvana
Petruzzella, Vittoria
author_facet Bianco, Angelica
Valletti, Alessio
Longo, Giovanna
Bisceglia, Luigi
Montoya, Julio
Emperador, Sonia
Guerriero, Silvana
Petruzzella, Vittoria
author_sort Bianco, Angelica
collection PubMed
description OBJECTIVES: Leber’s hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by a variable and reduced penetrance. Individuals carrying a primary LHON-causing mitochondrial DNA (mtDNA) mutation may either remain asymptomatic lifelong, as unaffected carriers, or develop sudden central visual loss that rapidly aggravates over some weeks. Over the years several genetic/environmental triggers able to modulate the risk of developing LHON have been proposed. We provided data supporting a possible correlation between LHON penetrance and the mtDNA copy number, a raw index of mitochondrial mass, whose increase could represent a compensatory response that cells implement to alleviate the pathogenic effect of the primary LHON-causing mtDNA mutations. DATA DESCRIPTION: We collected Italian and Spanish subjects harboring one of the three common LHON primary mutations, either in heteroplasmic or homoplasmic status. For each population we were able to discriminate between affected subjects presenting typical clinical tracts of LHON and LHON-causing mutation carriers showing no symptoms correlated with vision loss. Each subject has been characterized for the presence of a LHON primary mutation, for its status of homoplasmy or heteroplasmy, and for the mtDNA content per cell, expressed as relative mtDNA/nDNA ratio respect to controls. Additional clinical information is present for all the Italian subjects.
format Online
Article
Text
id pubmed-6302380
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63023802018-12-31 Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers Bianco, Angelica Valletti, Alessio Longo, Giovanna Bisceglia, Luigi Montoya, Julio Emperador, Sonia Guerriero, Silvana Petruzzella, Vittoria BMC Res Notes Data Note OBJECTIVES: Leber’s hereditary optic neuropathy (LHON) is a mitochondrial genetic disease characterized by a variable and reduced penetrance. Individuals carrying a primary LHON-causing mitochondrial DNA (mtDNA) mutation may either remain asymptomatic lifelong, as unaffected carriers, or develop sudden central visual loss that rapidly aggravates over some weeks. Over the years several genetic/environmental triggers able to modulate the risk of developing LHON have been proposed. We provided data supporting a possible correlation between LHON penetrance and the mtDNA copy number, a raw index of mitochondrial mass, whose increase could represent a compensatory response that cells implement to alleviate the pathogenic effect of the primary LHON-causing mtDNA mutations. DATA DESCRIPTION: We collected Italian and Spanish subjects harboring one of the three common LHON primary mutations, either in heteroplasmic or homoplasmic status. For each population we were able to discriminate between affected subjects presenting typical clinical tracts of LHON and LHON-causing mutation carriers showing no symptoms correlated with vision loss. Each subject has been characterized for the presence of a LHON primary mutation, for its status of homoplasmy or heteroplasmy, and for the mtDNA content per cell, expressed as relative mtDNA/nDNA ratio respect to controls. Additional clinical information is present for all the Italian subjects. BioMed Central 2018-12-20 /pmc/articles/PMC6302380/ /pubmed/30572950 http://dx.doi.org/10.1186/s13104-018-4025-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Data Note
Bianco, Angelica
Valletti, Alessio
Longo, Giovanna
Bisceglia, Luigi
Montoya, Julio
Emperador, Sonia
Guerriero, Silvana
Petruzzella, Vittoria
Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
title Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
title_full Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
title_fullStr Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
title_full_unstemmed Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
title_short Mitochondrial DNA copy number in affected and unaffected LHON mutation carriers
title_sort mitochondrial dna copy number in affected and unaffected lhon mutation carriers
topic Data Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302380/
https://www.ncbi.nlm.nih.gov/pubmed/30572950
http://dx.doi.org/10.1186/s13104-018-4025-y
work_keys_str_mv AT biancoangelica mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers
AT vallettialessio mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers
AT longogiovanna mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers
AT bisceglialuigi mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers
AT montoyajulio mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers
AT emperadorsonia mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers
AT guerrierosilvana mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers
AT petruzzellavittoria mitochondrialdnacopynumberinaffectedandunaffectedlhonmutationcarriers